Lepu Biopharma Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-23.00
-442.00
-131.00
-775.00
-1,218.00
-675.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-100.00
95.00
12.00
33.00
132.00
-77.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-42.00
-242.00
-308.00
-582.00
-758.00
-483.00
Cash Flow from Investing Activities
-166.00
-115.00
20.00
-86.00
-4.00
-827.00
Cash Flow from Financing Activities
691.00
329.00
19.00
1,223.00
467.00
1,551.00
Net Cash Inflow / Outflow
489.00
-26.00
-268.00
597.00
-298.00
240.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
7.00
1.00
0.00
44.00
-2.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Lepu Biopharma Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-23.0927561327969
1345.22124683278
-1,368.00
-101.72%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-100.915984169111
-99.5592145523496
-1.00
-1.36%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-42.9297731066844
1551.72548255096
-1,593.00
-102.77%
Cash Flow from Investing Activities
-166.103430413136
562.981009616293
-728.00
-129.50%
Cash Flow from Financing Activities
691.313154816577
-1971.84461609949
2,662.00
135.06%
Net Cash Inflow / Outflow
489.926925583722
151.784734895391
338.00
222.78%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
7.64697428696523
8.92285882762542
-1.00
-14.30%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 82.28% vs 21.58% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-42.93
-242.25
82.28%






